Table 1.

Mean Measured Diameters (in mm) of the Inflamed Area After Injection With PBS, FMLP, LPS, RANTES, and MCP-1

Treatment 50 μLMean of Major Diameters of 4 Samples (mm)P<
PBS (control) ND  —  
FMLP 10−6 mol/L 37.16 ± 8 .05 
LPS 10 ng 84.66 ± 10  —  
RANTES 20 ng 70.52 ± 12 (*) 
RANTES 10 ng 58.45 ± 11 (**) 
RANTES 5 ng  10 ± 10  —  
MCP-1 20 ng 22.1 ± 5 .01 
MCP-1 10 ng 20.3 ± 5 .01 
MCP-1 5 ng ND  —  
Treatment 50 μLMean of Major Diameters of 4 Samples (mm)P<
PBS (control) ND  —  
FMLP 10−6 mol/L 37.16 ± 8 .05 
LPS 10 ng 84.66 ± 10  —  
RANTES 20 ng 70.52 ± 12 (*) 
RANTES 10 ng 58.45 ± 11 (**) 
RANTES 5 ng  10 ± 10  —  
MCP-1 20 ng 22.1 ± 5 .01 
MCP-1 10 ng 20.3 ± 5 .01 
MCP-1 5 ng ND  —  

These values represent the mean ± SD of the major diameters of inflamed injection sites in four separate experiments. Each animal received a 50 μL intradermal injection and then was killed after 4 hours. The P values (Student's t-test) are calculated by comparing RANTES (20-10 ng)-treated animals, respectively.

Abbreviation: ND, not determined.

Close Modal

or Create an Account

Close Modal
Close Modal